Skip to content

J.P. Morgan Healthcare Conference, San Francisco

  • January 12, 2026 - January 15, 2026
  • Nanoform will be attending the J.P. Morgan Healthcare Conference in San Francisco from January 12 to 15.
    Our team, General Counsel & Chief Development Officer (CDO), Peter Hänninen, Chief Corporate Development Officer, Gonçalo Rebelo de Andrade, Deputy CCO, SVP BD US, Sergie Letser, and VP Business Development US, Christopher Worrall, will be on site to connect and discuss how Nanoform’s nanoparticle engineering technology supports innovative drug development.

    If you’re attending and would like to meet, feel free to reach out: info@nanoform.com

    Questions from investors, analysts and journalists